Podcast
MSL Talk: Tom Caravela, Conor McGladrigan, Kevin Peterson
From Clinical to Medical Device MSL and Beyond
Summary
In this episode, Maria Abunto joins Tom Caravela to discuss her journey from clinical practice to becoming a successful Medical Science Liaison (MSL) in the medical device industry. Maria shares insights on why clinicians are well-suited for MSL roles and the importance of mentors and career coaches. The conversation delves into transitioning within MSL roles, adapting to the pandemic's impact, and the evolving future of MSL work. Maria offers valuable advice for aspiring MSLs, touching on changes in metrics and KPIs. The episode concludes with a celebration of International MSL Day and a call for listener feedback.
Check out my latest podcast with Maria Abunto, Medical Science Liaison at Exact Sciences who discusses her path from clinician to a Medical Device MSL and beyond.
Maria shares….
What is a Medical Device MSL
How are Med Device MSLs different than therapeutic MSLs
Why is it so important to be organized for territory excellence
Advice for MSLs now and for the future
Medical Science Liaison, MSL roles, medical device industry, transitioning MSL, International MSL Day
Related Topics
You May Also Like
MSL Talk: Tom Caravela, Conor McGladrigan, Kevin Peterson
Podcast
MSL Talk: Tom Caravela
Over-Negotiation-How to Botch a Job Offer
Article
S.F. Oosting, J. Barriuso, A. Bottomley, M. Galotti, B. Gyawali, B. Kiesewetter, N.J. Latino, F. Martinelli, M. Pe, G. Pentheroudakis, F. Roitberg, H. Vachon, E.G.E. de Vries, M. Piccart, N.I. Cherny
Methodological and reporting standards for quality-of-life data eligible for European Society for Medical Oncology-Magnitude of Clinical Benefit Scale
Article
Dylan V Neel, David S Shulman, Clement Ma, Florence Bourgeois, Steven G DuBois
Sponsorship of oncology clinical trials in the United States according to age of eligibility
Article
Michael Z. Liao, Dan Lu, Matts Kågedal, Dale Miles, Divya Samineni, Stephanie N. Liu, Chunze Li
Model-Informed Therapeutic Dose Optimization Strategies for Antibody-Drug Conjugates in Oncology: What Can We Learn From US Food and Drug Administration-Approved Antibody-Drug Conjugates?
Article
Karen Geary